When the gut speaks to the prefrontal cortex

Several recent studies (Frontiers in Psychiatry 2024, Scientific Reports 2025) document a specific microbial signature in adults with ADHD: overrepresentation of Odoribacter and Eggerthella, underrepresentation of Faecalibacterium prausnitzii, one of the major butyrate producers. This signature correlates with markers of low-grade systemic inflammation.

Some bacterial genera produce phenolic compounds (p-cresol, indole-3-acetic) that interfere with dopaminergic signalling and neuroinflammation. The microbiome is not the sole cause of ADHD, but it is a quantitatively identified modulator, and it is a target accessible to nutritional interventions.

Short-chain fatty acids (SCFAs) are produced by bacterial fermentation of fibres in the colon. Butyrate feeds intestinal epithelial cells and maintains barrier integrity. Propionate and acetate, taken up into circulation, modulate systemic inflammation and neuronal signalling.

More precisely, SCFAs support expression of tyrosine hydroxylase" data-lang="en">tyrosine hydroxylase, the rate-limiting enzyme of dopaminergic synthesis, and of tryptophan hydroxylase, which regulates the serotonergic pathway. A microbiome poor in butyrate producers therefore generates fewer signals sustaining the monoaminergic pathways. This is one of the best-documented mechanisms of the gut-brain axis in ADHD.

The vagus nerve is the major ascending communication route between gut and brain. It carries signals from enterochromaffin cells (which produce 90% of the body's serotonin), from local inflammation, and from bacterial molecules (GABA, SCFAs, lipopolysaccharides).

Altered vagal signalling shifts activation of the prefrontal cortex and of the HPA axis (the stress axis). Working on vagal tone (slow breathing, graded cold exposure, preserved deep sleep) is one of the indirect but documented levers to support an ADHD brain beyond pharmacology.

The most recent data (Scientific Reports 2025) show that methylphenidate measurably alters the microbiome of treated adults: reduced alpha diversity, decrease in Ruminococcaceae (major butyrate producers), and lower faecal SCFA output. 'Destroy' is too strong, but the signature thins out in a direction that overlaps with what is already seen in untreated ADHD.

Clinically, this suggests that actively supporting the microbiome alongside methylphenidate is not a comfort measure but a strategy to preserve the neurochemical cofactors produced by bacteria. This is precisely the point that standard psychiatric care does not cover.

Documented nutritional levers are concrete:

• Fermentable fibres: inulin, FOS, GOS, pulses, semi-complete grains, root vegetables. Gradual increase to avoid transition dysbiosis.
• Polyphenols: berries, unsweetened cocoa, green tea, extra virgin olive oil. Growth substrates for Akkermansia muciniphila and Faecalibacterium.
• Fermented foods: kefir, raw sauerkraut, miso, kimchi. Live strain intake, contribution to diversity.
• Probiotic strains with data: Lactobacillus rhamnosus GG, Bifidobacterium longum 1714 (anxiety and stress), Lactobacillus plantarum DR7. Chosen according to profile, not as blind supplementation.

Effect is measured in weeks to months, not days, and consolidates with sleep and glycaemia cared for in parallel.